Enhanced inhibitory effects of extracts from Ginkgo biloba L. leaves encapsulated in hybrid liposomes on the growth of tumor cells in vitro

Biochemical Engineering Journal

Volumn 12, Issue 2, 2002, Pages 125-130

  Yamamoto, Shinjiro ^a   Nakano, Koji ^a   Ishikawa, Chihiro ^a   Yamamoto, Megumi ^a   Matsumoto, Yoko ^a   Iwahara, Masayoshi ^a   Furusaki, Shintaro ^a   Ueoka, Ryuichi ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

B 16 mouse melanoma cell; Ginkgo biloba L.; Human lung carcinoma cell; Hybrid liposomes; Inhibitory effect

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; GINKGO BILOBA EXTRACT; LIPOSOME;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ENCAPSULATION; GROWTH INHIBITION; HYBRID; HYDROPHOBICITY; LUNG ADENOCARCINOMA; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; SOLUBILITY; SOLUBILIZATION; THROMBOCYTE ACTIVATION; TUMOR CELL CULTURE; TUMOR GROWTH;

GINKGO BILOBA;

EID: 0036837939     PISSN: 1369703X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-703X(02)00065-7     Document Type: Article

References (24)

1. R.N. Patel, Tour de paclitaxel, Annu. Rev. Microbiol. 98 (1998) 361-395.
2. Ginkgo biloba, Woodland Publishing, 1996, pp. 5-8.
3. S. Kawaii, Y. Tomono, E. Katase, K. Ogawa, M. Yano, Antiproliferative activity of flavonoids on several cancer cell lines, Biosci. Biotechnol. Biochem. 63 (1999) 896-899.
4. H.K. Wang, The therapeutic potential of flavonoids, Expert Opin. Investing. Drugs 9 (2000) 2103-2119.
5. K. Iwashita, M. Kobori, K. Yamaki, T. Tsushida, Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells, Biosci. Biotechnol. Biochem. 64 (2000) 1813-1820.
6. T.M. Elattar, A.S. Virji, The inhibitory effects of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro, Anticancer Res. 20 (2000) 1733-1738.
7. D.W. Lamson, M.S. Bringnall, Antioxidants and cancer, Part 3: Quercetin, Altern. Med. Rev. 5 (2000) 196-208.
8. G. Gregoriadis, Engineering liposomes for drug delivery: progress and problems, Trends Biotechnol. 13 (1995) 527-537.
9. F. Szoka Jr., D. Papahadjopoulos, Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation, Proc. Natl. Acad. Sci. USA 75 (1978) 4194-4198.
10. A. Kanno, Y. Terada, K. Tsuzaki, Y. Matsumoto, R. Ueoka, Therapeutic effects of hybrid liposomes on mice model of lung carcinoma, Drug Delivery Syst. 14 (1999) 37-42.
11. C. Imamura, Y. Kemura, Y. Matsumoto, R. Ueoka, Remarkable inhibitory effects of hybrid liposomes on the growth of HL-60 cells coupled to induction of apoptosis, Biol. Pharm. Bull. 20 (1997) 1119-1121.
12. Y. Matsumoto, C. Imamura, T. Ito, C. Taniguchi, R. Ueoka, Specific hybrid liposomes composed of phosphatidylcholine and polyoxylenealkyl ether with markedly enhanced inhibitory effects on the growth of tumor cells in vitro, Biol. Pharm. Bull. 18 (1995) 1456-1458.
13. Y. Matsumoto, T. Kato, S. Iseki, H. Suzuki, K. Nakano, M. Iwahara, R. Ueoka, Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells, Bioorg. Med. Chem. Lett. 9 (1999) 1937-1940.
14. R. Ueoka, Y. Matsumoto, A. Kanno, K. Tsuzaki, H. Ichihara, Marked therapeutic effects of dimyristoylphosphatidylcholine liposomes on carcinoma mice model in vivo, Biol. Pharm. Bull. 23 (2000) 1262-1263.
15. R. Ueoka, Y. Matsumoto, R.A. Moss, S. Swarup, A. Sugii, K. Harada, J. Kikuchi, Y. Murakami, Membrane matrix for the hydrolysis of amino acid esters with marked enantioselectivity, J. Am. Chem. Soc. 110 (1988) 1588-1595.
16. M. Ishiyama, M. Siga, K. Sakamoto, M. Mizoguchi, P.-G. He, A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye, Chem. Pharm. Bull. 41 (1993) 1118-1122.
17. D.J. Mitchell, B.W. Ninham, Micelles, vesicles and microemulsions, J. Chem. Soc., Faraday Trans. 77 (1981) 601-629.
18. J.N. Israelachvili, D.J. Mitchell, B.W. Ninham, Theory of self-assembly of lipid bilayers and vesicles, Biochim. Biophys. Acta 470 (1977) 185-201.
19. C. Imamura, A. Kanno, C. Mitsuoka, S. Kitajima, H. Inoue, M. Iwahara, Y. Matsumoto, R. Ueoka, Specific inhibitory effect of hybrid liposomes on the growth of hybridoma cell in vitro, Yakugaku Zasshi 116 (1996) 942-950.
20. H. Itokawa, N. Totsuka, K. Nakahara, K. Takeya, J.-P. Lepoittevin, Y. Asakawa, Antitumor principles from Ginkgo biloba L., Chem. Pharm. Bull. 35 (1987) 3016-3020.
21. M. Yoshida, T. Sakai, N. Hosokawa, N. Marui, K. Matsumoto, A. Fujioka, H. Nishino, A. Aoike, The effect of quercetin on cell cycle progression and growth of human gastric cancer cells, FEBS Lett. 260 (1990) 10-13.
22. F.O. Ranelletti, R. Ricci, L.M. Larocca, N. Maggiano, A. Capelli, G. Scambia, P. Benedetti Panici, S. Mancuso, C. Rumi, M. Piantelli, Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors, Int. J. Cancer 50 (1992) 486-492.
23. G. Scambia, F.O. Ranelletti, P. Benedetti Panici, M. Piantelli, G. Bonanno, R. De Vincenzo, G. Ferrandina, L. Pierelli, A. Capelli, S. Mancuso, Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type Il estrogen-binding sites, Cancer Chemother. Pharmacol. 28 (1991) 255-258.
24. S.-J. Lee, J.-H. Sung, C.-K. Moon, B.-H. Lee, Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin, Cancer Lett. 144 (1999) 39-43.